Iterum Therapeutics

Iterum Therapeutics plc is a clinical-stage pharmaceutical company headquartered in Dublin, Ireland, focused on developing novel anti-infective medications to treat multi-drug resistant (MDR) bacterial infections. Its lead product, ORLYNVAH (sulopenem), is described as the first oral and IV penem antibiotic targeting gram-negative resistant infections. The company was surfaced as a portfolio company of canaan-partners and added to the API Evangelist network. Iterum Therapeutics is a pharmaceutical/biotech company and does not operate a public developer API; as of March 2026 the company entered liquidation following a High Court order in Ireland.

Iterum Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Pharmaceuticals, Biotechnology, Anti-Infectives, and Antibiotics.

Iterum Therapeutics’ developer surface includes support and 4 more developer resources.

🌐 Visit website 📡 Source on GitHub

8.9/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-20 · rubric v0.12.0

0 APIs

CompanyPharmaceuticalsBiotechnologyAnti-InfectivesAntibioticsHealthcareClinical StageDrug Development

Kin Score

Kin Score How this is scored →
scored 2026-08-20 · rubric v0.12.0

Composite quality — 8.9/100 · minimal

Contract Quality 0.0 / 21

Developer Ergonomics 0.8 / 17

Access Clarity 3.6 / 17

Operational Transparency 0.0 / 11

Contract Governance 0.0 / 10

Discoverability 4.3 / 9

Regulatory Posture 1.5 / 15

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 10

Documented Reversibility 0 / 6

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

A2A Agent Card 0 / 8

Dry-Run / Simulate Mode 0 / 4

Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.

The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/iterum-therapeutics: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Resources

Operate 1

Status, limits, changes, and where to get help

Support

Support

Commercial 2

Pricing, plans, and the legal terms of use

PrivacyPolicy

PrivacyPolicy

TermsOfService

TermsOfService

Company 2

The organization behind the API

Website

Website

Investors

Investors

Source (apis.yml)

aid: iterum-therapeutics
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/iterum-therapeutics.png
name: Iterum Therapeutics
description: Iterum Therapeutics plc is a clinical-stage pharmaceutical company headquartered in Dublin, Ireland, focused
  on developing novel anti-infective medications to treat multi-drug resistant (MDR) bacterial infections. Its lead product,
  ORLYNVAH (sulopenem), is described as the first oral and IV penem antibiotic targeting gram-negative resistant infections.
  The company was surfaced as a portfolio company of canaan-partners and added to the API Evangelist network. Iterum Therapeutics
  is a pharmaceutical/biotech company and does not operate a public developer API; as of March 2026 the company entered liquidation
  following a High Court order in Ireland.
url: https://raw.githubusercontent.com/api-evangelist/iterum-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- canaan-partners
x-tier: stub
x-tier-reason: portfolio-lead
x-industry: pharmaceutical
x-status: liquidation
x-status-note: Entered liquidation March 2026 following a High Court order in Ireland.
specificationVersion: '0.23'
created: '2026-07-17'
modified: '2026-07-19'
tags:
- Company
- Pharmaceuticals
- Biotechnology
- Anti-Infectives
- Antibiotics
- Healthcare
- Clinical Stage
- Drug Development
tags_raw:
- Company
- Pharmaceutical
- Biotechnology
- Anti-Infectives
- Antibiotics
- Healthcare
- Clinical-Stage
- Drug Development
apis: []
common:
- type: Website
  url: https://www.iterumtx.com
- type: Investors
  url: https://ir.iterumtx.com
- type: Support
  url: https://www.iterumtx.com/contact
- type: PrivacyPolicy
  url: https://www.iterumtx.com/privacy-statement
- type: TermsOfService
  url: https://www.iterumtx.com/terms-of-use
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence